
Lundbeck elects new chairman
pharmafile | February 21, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Lundbeck
Lundbeck has announced it will be electing Håkan Björklund as its new chairman as Mats Pettersson steps down.
Pettersson, a member of Lundbeck’s Board of directors since 2003, and chairman since 2011, has announced that he will not be seeking re-election.
Björklund (pictured) said: “I have in-depth knowledge of Lundbeck after two years as a board member, and I look forward to contributing to Lundbeck’s progress and future growth in my role as chairman.”
Pettersson added: “I have held a seat on the Board of directors of Lundbeck for nearly ten years, acting as chairman for close to two years. I have had ten very exciting years, and it has been a privilege to contribute to developing Lundbeck and expanding the company’s strong position.”
He continued: “Lundbeck is well prepared to face the future, building on its strong platform for long-term growth, and I have decided that this was the right time to pass the baton to a new board member and chairman”.
New board candidate
Lundbeck’s Board of directors will also nominate Lars Rasmussen, chief executive of Coloplast A/S, as new board member at the next annual general meeting.
The Board will also propose re-election of Christian Dyvig, Thorleif Krarup, Jes Østergaard and Melanie Lee, and expects to re-elect Christian Dyvig as deputy chairman of the Board of directors.
Related Content

Otsuka and Lundbeck gain FDA approval for supplemental New Drug Application for dementia drug
Japan-based healthcare company Otsuka Pharmaceutical and Danish pharma company Lundbeck have announced that the US …

Lundbeck to restructure R&D, shedding up to 160 jobs
Danish neuroscience specialist Lundbeck has announced it will be implementing a restructure of its Research …

Lundbeck’s Vyepti secures US approval for migraine prevention
Lundbeck’s Vyepti (eptinezumab-jjmr) has secured approval from the FDA, it has emerged, for the prevention …






